
Stock Movers Hims & Hers Sinks; Kroger's Next CEO; STMicro Rises
Feb 9, 2026
Coverage of a telehealth company pulling a Wegovy-copy pill amid regulatory scrutiny. Discussion of Kroger naming a new CEO as the supermarket reshapes strategy after a failed megadeal. A chipmaker's stock jumps on an expanded collaboration with Amazon AWS tied to AI data center opportunities.
AI Snips
Chapters
Transcript
Episode notes
Copycat Drug Backlash Sparks Stock Drop
- Hims & Hers shares plunged after pulling a copycat weight-loss pill amid regulatory and legal scrutiny.
- The episode shows rapid reputational and market risk for startups copying blockbuster drugs.
Big Pharma Gains From Copycat Controversy
- Novo Nordisk stock rose as the maker of the original pill benefited from the controversy.
- Broad consumer demand is driving big pharma to invest heavily in marketing, including Super Bowl ads.
Expect Store-Focused Turnaround At Kroger
- Kroger plans to appoint Greg Foran as CEO to reset strategy after leadership turmoil and a failed merger.
- Watch for moves on store experience, pricing, and workforce pay that Foran emphasized at Walmart.
